Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mannitab Pharma Specialities manufactures specialty mannitol grades for direct compression and other pharmaceutical excipient uses. Acquired majority by Ingredion, it serves pharmaceutical and nutraceutical customers requiring excipient solutions in high-value drug formulations. No evidence of clinical programs; business is focused on ingredient manufacturing for pharma production[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mannitab Pharma Specialities.